| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.12 | 0.4 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.11 | 0.5 |